Summary
This blog explores the Hexagon Nutrition IPO, a ₹138.87 crore bookbuilt mainboard IPO comprising an offer for sale of 30,859,704 equity shares, priced between ₹42.00 and ₹45.00 per share.It provides a detailed overview of the IPO, covering IPO timeline, lot size, reservation details, GMP trends, financial performance, and other important issue-related information.Examine Hexagon Nutrition IPO, along with business operations, strengths, risks, and financial position of the company, to evaluate the offering and make informed investment decisions.
The Hexagon Nutrition IPO is a bookbuilt mainboard issue valued at ₹138.87 crore. The IPO is structured solely as an offer for sale, under which approximately 30,859,704 equity shares will be offered to investors.
The bidding period for the Hexagon Nutrition IPO runs from 5 June 2026 to 9 June 2026. The allotment process is expected on 10 June 2026, with the shares to tentatively commence trading on the NSE and BSE on 12 June 2026.
The offer has been launched with a valuation ranging between ₹42.00/share and ₹45.00/share. Retail applicants can participate by bidding for 333 shares. Based on the highest offer price of ₹45.00, the required investment stands at ₹14,985.00.
For the non-institutional investor segment, the minimum bid requirement works out to ₹2.09 lakh for sNIIs and approximately ₹10.04 lakh for bNIIs.
Details of the Hexagon Nutrition IPO
The table below summarises the essential details of the Hexagon Nutrition IPO, including its size, timeline, pricing, and investment requirements.
| IPO Open | 5 June 2026 |
| IPO Close | 9 June 2026 |
| Face value | ₹1.00/share |
| Price Band | ₹42.00/share – ₹45.00/share |
| Issue price | – |
| IPO Lot Size | 333 shares |
| Offer-for-sale | 30,859,704 Equity Shares (₹138.87 crore) |
| Fresh issue | – |
| Issue Type | Mainboard/Book-built |
| Listing | NSE & BSE |
| Total Issue Size (₹ Crore) | ₹138.87 crore (30,859,704 Equity Shares) |
| Minimum Investment (Retail) | ₹14,985.00 (333 shares x upper band) |
Timeline of the Hexagon Nutrition IPO
The table below presents the complete schedule for the Hexagon Nutrition IPO, including key dates from subscription to listing.
| Bid Open Date | 5 June 2026 |
| Bid Close Date | 9 June 2026 |
| Allotment | 10 June 2026 |
| Refunds Initiated | 11 June 2026 |
| Share Credit Date | 11 June 2026 |
| Listing | 12 June 2026 |
| UPI mandate Cut-off time | 9 June 2026 (05:00 PM) |
Hexagon Nutrition Limited Financial Highlights
The following table highlights important financial figures and ratios of Hexagon Nutrition Limited for the reported periods.
| KPIs | 2025 | 2024 | 2023 |
| ROE (%) | 10.47 | 7.21 | 3.5 |
| ROCE (%) | 17.06 | 11.12 | 5.94 |
| Debt-Equity Ratio (in times) | 0.14 | 0.21 | 0.32 |
| RoNW (%) | 3.55 | 6.93 | 12.46 |
| PAT Margin (%) | 7.36 | 4.01 | 2.07 |
| EBITDA Margin (%) | 12.33 | 8.36 | 6.17 |
| Price-Book Value | 2.83 | – | – |
Hexagon Nutrition Ltd–Financial Information
| 2025 | 2024 | 2023 | |
| Revenue | 324.93 | 297.73 | 278.50 |
| Assets | 261.36 | 250.54 | 288.90 |
| Profit After Tax | 24.38 | 12.21 | 5.82 |
(Amount in ₹ crore)
Hexagon Nutrition IPO–Subscription Status
Subscription Data Unavailable!
Subscription details will be published once the IPO opens for bidding.
The issue will accept applications from 10:00 AM to 5:00 PM during the subscription period.
Hexagon Nutrition IPO–Grey Premium Market (GMP)
As of 9:54 AM on 1 June 2026, the Hexagon Nutrition IPO GMP is ₹0.00.
Based on the upper price band of ₹45.00/share, the estimated listing price is also ₹45.00, indicating no premium or discount in the grey market at present. The current GMP levels suggest an expected listing gain of 0.00%.
| Date | GMP (₹) | Est. Listing Price | Est. Listing Profit | Latest Updated |
| 1 June 2026 | ₹0.00 | ₹45.00(0.00%) | ₹0.00 | 01/06/2026 (09:54 AM) |
| 31 May 2026 | ₹0.00 | ₹45.00(0.00%) | ₹0.00 | 31/05/2026 (11:34 PM) |
| 30 May 2026 | ₹0.00 | ₹45.00(0.00%) | ₹0.00 | 30/05/2026 (11:36 PM) |
| 29 May 2026 | ₹0.00 | ₹45.00(0.00%) | ₹0.00 | 29/05/2026 (11:36 PM) |
| 28 May 2026 | ₹0.00 | ₹45.00(0.00%) | ₹0.00 | 28/05/2026 (11:37 PM) |
| 27 May 2026 | ₹0.00 | ₹45.00(0.00%) | ₹0.00 | 27/05/2026 (11:37 PM) |
| 26 May 2026 | ₹0.00 | ₹45.00(0.00%) | ₹0.00 | 26/05/2026 (11:32 PM) |
Note: Grey Market Premium (GMP) reflects unofficial trading activity and may fluctuate significantly based on market conditions and investor interest in the IPO.
Hexagon Nutrition IPO–Reservation
The table below details the share allocation across various investor categories under the IPO.
| Investor Classification | % Allocation |
| QIBs | Maximum 50% |
| NIIs | Minimum 15% |
| Individual Investor | Minimum 35% |
| Total | 100% |
Hexagon Nutrition IPO–Lot Size
The following details explain the minimum bid requirements for each investor category. A retail application starts at 333 shares, and further bids may be submitted only in increments of 333 shares.
| Application | Lot Size | Shares | Amount |
| Retail Minimum Application | 1 | 333 | ₹14,985.00 |
| Retail Maximum Application | 13 | 4,329 | ₹1,94,805.00 |
| S-HNI Minimum Application | 14 | 4,662 | ₹2,09,790.00 |
| S-HNI Maximum Application | 66 | 21,978 | ₹9,89,010.00 |
| S-HNI Minimum Application | 67 | 22,311 | ₹10,03,995.00 |
Hexagon Nutrition IPO–Anchor Investors Details
The table below presents the anchor investor allocation for the Hexagon Nutrition IPO.
| Bidding Opens On | 4 June 2026 |
Hexagon Nutrition IPO–Prospectus
The following documents contain detailed information about the IPO, the company, its financials, and associated risks.
About Hexagon Nutrition Limited
Established on 27 May 1993, Hexagon Nutrition Limited is a research-focused nutrition company led by Chairman and Executive Director Arun Purushottam Kelkar. The company operates across multiple nutrition categories, serving individual consumers as well as institutional customers.
Its activities are spread across three areas of the nutrition industry:
- Branded Wellness and Clinical Nutrition (B2C): Consumer-focused health and nutrition products marketed under the company’s brands.
- Premix Formulations (B2B2C): Customised micronutrient premixes supplied to food, beverage, and nutrition companies.
- Ready-to-Use Foods (RUFs) and Micronutrient Powders (MNPs): Nutrition products created for large-scale health and welfare interventions.
| Name | |
| Book Running Lead Managers (BRLM) | Cumulative Capital Pvt Ltd |
| Catalyst Capital Partners Pvt Ltd | |
| IPO Registrar | KFin Technologies Ltd |
Objectives of Hexagon Nutrition
The Hexagon Nutrition IPO involves only the sale of existing equity shares, meaning the fundraising benefits will flow to the shareholders offering those shares.
Hexagon Nutrition Limited–Strengths
- Strong industry experience: The company has built more than two decades of experience in micronutrient premix formulation and manufacturing.
- Established nutrition brands: The company markets a portfolio of wellness and clinical nutrition brands across domestic and international markets.
- Customer retention: A significant portion of revenue is supported by continuing business from existing customers across key markets.
- Research expertise: The company leverages in-house development capabilities to expand and refine its product range.
Hexagon Nutrition Limited–Risks
- Dependence on premix formulations: The premix formulations segment contributes a significant share of the overall revenue.
- Customer concentration risk: Changes in purchasing patterns among major customers could affect business performance.
- Facility reconstruction risk: The reconstruction activities at the Nashik facility could temporarily affect production and operational efficiency.
- Quality and compliance risk: The product quality issues could result in liabilities, reputational damage, and financial setbacks.
Hexagon Nutrition IPO–Review
Hexagon Nutrition derives its business from multiple nutrition categories and has reported stronger earnings performance in recent years.
The company reported growth in revenue and profit over the last three financial years, while maintaining a relatively low debt-equity ratio.
However, the IPO is entirely an offer-for-Sale, and the current GMP of ₹0.00 indicates neutral grey market sentiment. Overall, the investors may consider the issue based on the long-term business fundamentals of the company rather than listing expectations.
Other Recent IPO List
Explore other live and upcoming IPOs in India for 2026:
| Q-Line Biotech IPO | SMR Jewels IPO |
| Bio Medica Laboratories IPO | Merritronix IPO |
| Autofurnish IPO | M R Maniveni Foods IPO |
| Yaashvi Jewellers IPO | Harikanta Overseas IPO |
Hexagon Nutrition IPO FAQs
The Hexagon Nutrition IPO is a ₹138.87 crore book-built public issue comprising an offer-for-sale (OFS) of 30,859,704 equity shares. The issue opens on 5 June 2026 and closes on 9 June 2026.
Investors can apply for the Hexagon Nutrition IPO through their stockbroker’s platform using the ASBA facility or through UPI-supported applications offered by registered brokers and banking channels.
Hexagon Nutrition has an established presence in the nutrition industry, improving profitability and low leverage. However, the issue is entirely an OFS, and the current GMP suggests neutral market sentiment. Investors should assess the valuation and business prospects before investing.
Based on the latest GMP of ₹0.00, the estimated listing price is ₹45.00 per share, indicating no expected listing gain. The actual returns may differ depending on market conditions and investor demand.
The Hexagon Nutrition IPO will open for subscription on 5 June 2026 and will remain available for bidding until 9 June 2026.
The minimum application size for retail investors is one lot comprising 333 shares. At the upper price band of ₹45.00 per share, the minimum investment amount is ₹14,985.
The allotment for the Hexagon Nutrition IPO is expected to be finalised on 10 June 2026, subject to completion of the subscription process.
The Hexagon Nutrition IPO shares are tentatively scheduled to be listed on the NSE and BSE on 12 June 2026.
